C4 THERAPEUTICS INC. - COMMON STOCK
5.3800
04-October-24 14:59:56
15 minutes delayed
Stocks
+0.0400
+0.75%
Today's range
5.1800 - 5.4800
ISIN
N/A
Source
NASDAQ
-
C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 15:01:00 By Nasdaq GlobeNewswire
-
12 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
28 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
20 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
01 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Chief Financial Officer Succession
05 Sep 2023 15:01:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
08 Aug 2023 06:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
20 Jun 2023 06:00:00 By Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
04 May 2023 06:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
23 Feb 2023 06:00:02 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at Two Virtual February 2023 Conferences
08 Feb 2023 06:00:00 By Nasdaq GlobeNewswire
-
30 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 06:00:01 By Nasdaq GlobeNewswire
-
C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 06:00:01 By Nasdaq GlobeNewswire